Consolidated Statutes and Regulations
Consolidated Statutes
Consolidated Regulations
Annual Statutes and Regulations
Annual Statutes
Annual Regulations
Additional information
Québec Official Publisher
What’s new?
Information note
Policy of the Minister of Justice
Laws: Amendments
Laws: Provisions not in force
Laws: Provisions brought into force
Annual Statutes: PDF versions since 1996
Regulations: Amendments
Annual Regulations: PDF versions since 1996
Court Decisions
P-12, r. 6 - Regulation respecting the medications that a podiatrist who obtained a permit to practise before 1976 may administer or prescribe
Schedule
Disposition versions
SCHEDULE I
(ss. 1 and 2)
1. Any medication listed below, subject to the restrictions indicated:
| Medications | Restrictions |
| Aluminium and its salts | |
| Amcinonide | |
| Anthralin | |
| Silver sulfadiazine | |
| Bacitracin and its salts | |
| Beclomethasone and its salts | |
| Benzalkonium | |
| Benzocaine | |
| Betamethasone dipropionate | |
| Betamethasone valerate | |
| Bupivacaine and its salts | Pharmaceutical form intended for administration by injection for local use only |
| Calcipotriol | |
| Calcitriol | |
| Camphor | |
| Cantharidin | |
| Cetirizine hydrochloride | |
| Chlorhexidine and its salts | |
| Ciclopirox olamine | |
| Cinchocaine (dibucaine) | |
| Clioquinol | |
| Clobetasol proprionate | |
| Clotrimazole | |
| Cyproheptadine hydrochloride | |
| Desonide | |
| Desoximetasone | |
| Diphenhydramine | Pharmaceutical form intended for oral and topical administration |
| Efinaconazole | |
| Epinephrine (adrenaline) | |
| Erythromycin | Powder extemporaneous mixture or topical preparation |
| Ethyl chloride | |
| Fluocinolone acetonide | |
| Fluocinode | |
| Formalin | |
| Framycetin sulfate | |
| Fusidic acid | |
| Gentamicin sulfate | |
| Mineral tar | |
| Vegetal tar | |
| Gramicidin | |
| Hexachlorophene | |
| Hydrocortisone and its salts | Pharmaceutical form intended for topical administration |
| Hydroxyzine hydrochloride | Pharmaceutical form intended for oral administration |
| Povidone iodine | |
| Ketoconazole | Pharmaceutical form intended for topical administration |
| Lactic acid | |
| Lidocaine and its salts | Pharmaceutical form intended for administration by injection for local use only |
| Loratadine | Pharmaceutical form intended for oral administration |
| Lorazepam | Pharmaceutical form intended for oral and sublingual administration |
| Quantity limited to 4 tablets | |
| Mepivacaine | Pharmaceutical form intended for administration by injection for local use only |
| Methylpolysiloxanes (dimethicone) | |
| Methylprednisolone acetate | |
| Miconazole nitrate | |
| Mometasone furorate | |
| Mupirocin | |
| Neomycin sulfate | |
| Nystatin, its salts and derivatives | Pharmaceutical form intended for topical administration |
| Dressings and products associated with the treatment of wounds and alterations of the skin and teguments | |
| Phenol | |
| Podophyllin | |
| Polymyxin B sulfate | |
| Pramoxine | |
| Promethazine hydrochloride | |
| Resorcinol and its salts | |
| Triethanolamine salicylate | |
| Salicylic acid | |
| Silicone (dimethicone) | |
| Sulphur colloidal | |
| Sulphur precipitate | |
| Sulphur sublimate | |
| Tazarotene | |
| Tolnaftate | |
| Triamcinolone acetonide | Pharmaceutical form intended for topical administration |
| Trichloroacetic acid | |
| Trimeprazine tartrate | |
| Urea | Pharmaceutical form intended for topical administration, with a concentration of 40% or less |
2. Any other medication intended for topical or oral administration that is not listed in Schedule I of the Regulation respecting the terms and conditions for the sale of medications (chapter P-10, r. 12).
3. Any combination of medications of this Schedule, subject to the applicable restrictions.
SCHEDULE I
NOTE : Medications without specification are intended for topical application.
________________________________________________________________
Substances Specification
________________________________________________________________
Acetaminophen Pharmaceutical forms intended
for oral and rectal
administration
Acetic, glacial acid
Acetylsalicylic, Pharmaceutical forms intended
for oral administration
Aluminium and its salts
Almond, sweet oil
Amino acids
Amcinonide Quantity limited for 30 days
Anthralin (dithranol)
Silver nitrate
Silver sulfadiazine
Colloidal oatmeal
Bacitracin and its salts
Beclomethasone and its salts
Benzalkonium
Benzocaine
Betamethasone benzoate
Betamethasone Quantity limited for 30 days
dipropionate
Betamethasone valerate
Bupivacaine and Pharmaceutical forms intended
its salts for administration by injection
for local use only
Calcipotriol
Calcium acetate
Camphor
Cantharin
Capsaicin
Cetrimide
Cetirizine Pharmaceutical form intended
hydrochloride for oral administration
Chlorhexidine and its salts
Chlorphenesin
Chlorprocaine Pharmaceutical form intended
hydrochloride for administration by injection
for local use only
Ciclopirox olamine
Cinchocaine
Clioquinol
(iodochlorhydroxyquin)
Clobetasol Quantity limited for 30 days
proprionate
Clobetasone butyrate
Clotrimazole
Collagenase
Dakin’s solution
Desonide
Desoximetasone Quantity limited for 30 days
Deoxyribonuclease
Dichloracetic acid
Diflucortolone Quantity limited for 30 days
valerate
Diphenhydramine Pharmaceutical forms intended
for oral and topical
administration
Econazole nitrate
Epinephrine Pharmaceutical forms for the
(adrenaline) emergency treatment of
anaphylactic reactions in
the form of self-injector or
vial
Pharmaceutical form associated
with local anaesthetics
Erythromycin
Ethyl chloride
Fibrinolysin
Flumetasone pivalate
Fluocinolone Quantity limited for 30 days
acetonide
Fluocinode Quantity limited for 30 days
Formalin
Framycetin sulfate
Fusidic acid
Gentamicin sulfate
Gentian, violet
Mineral and vegetal tar
Gramicidin
Halcinodide Quantity limited for 30 days
Hexachlorophene
Mineral oil
Hydrocortisone and its salts
Hydroxyzine Pharmaceutical form intended
hydrochloride for oral administration
Povidone iodine
Iodine tincture
Isopropyl myristate
Ketoconazole
Lactic acid
Lanolin
Lidocaine and Pharmaceutical forms intended
its salts for topical application and
administration by injection
for local use only
Loratadine Pharmaceutical form intended
for oral administration
Lorazepam Pharmaceutical form intended
for oral and sublingual
administration in anticipation
of surgical procedures,
containing 0.5 mg or 1 mg
of Lorazepam per tablet
Quantity limited to 4 tablets
Mafenide and its salts
Menthol
Mepivacaine Pharmaceutical form intended
for administration by injection
for local use only
Methylpolysiloxanes
Methylprednisolone acetate
Miconazole nitrate
Mometasone furorate
Mupirocin
Neomycin sulfate
Nystatin
Oxiconazole
Phenol
Podophyllin
Polymyxin B sulfate
Pramoxine
Prilocaine Pharmaceutical forms intended
for topical application and
administration by injection
for local use only
Procaine Pharmaceutical form intended
for administration by injection
for local use only
Resorcinol and its salts
Diethylamine salicylate
Magnesium salicylate
Methyl salicylate
Triethanolamine salicylate
Salicylic acid
Synthetic sebum
Silicone
Sodium thiosulfate
Sulphur, colloidal,
precipitate or sublimate
Tazarotene
Terbinafine
Tetracaine and Pharmaceutical forms intended
its salts for topical application and
administration by injection
for local use only
Tioconazole
Tolnaftate
Triamcinolone Quantity limited for 30 days
acetonide
Trichloroacetic acid
Urea Pharmaceutical form intended
for topical application, with
a concentration of 30% or less
White petroleum jelly
Zinc oxide
